May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach

Autoimmune Diseases

Volumn 1, Issue 1, 2010, Pages

  Riccio, Paolo ^a,b   Rossano, Rocco ^a   Liuzzi, Grazia Maria ^c  

^a UNIVERSITY OF BASILICATA   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3 BENZENE TRIOL; ACETYLCYSTEINE; ANTIBODY; CAFFEIC ACID; CAROTENOID; CATECHIN; CURCUMIN; DAIDZEIN; EPIGALLOCATHECHIN; GENISTEIN; GLUTATHIONE; HYDROXYTYROSOL; LIVER X RECEPTOR; LYCOPENE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; POLYPHENOL; POLYUNSATURATED FATTY ACID; PROANTHOCYANIDIN; PYROGALLOL; QUERCETIN; RESVERATROL; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; SELENIUM; THIOCTIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D; ZINC;

ACETYLATION; ADAPTIVE IMMUNITY; ALLERGIC ENCEPHALOMYELITIS; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; AUTISM; AUTOIMMUNITY; BIOSYNTHESIS; CATABOLISM; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CELL PROLIFERATION; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DNA BINDING; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; EPSTEIN BARR VIRUS; EXERCISE; FATTY ACID METABOLISM; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC PREDISPOSITION; GLYCOSYLATION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; ISCHEMIC HEART DISEASE; LIPOGENESIS; METABOLIC RATE; METHYLATION; MICROGLIA; MILK; MOLECULAR BIOLOGY; MOLECULE; MULTIPLE SCLEROSIS; MYELIN SHEATH; NATURAL KILLER T CELL; NONHUMAN; NUTRIENT; NUTRITION; OXIDATIVE STRESS; PATHOGENESIS; PATIENT SAFETY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SUN EXPOSURE; TH17 CELL; TRANSCRIPTION REGULATION; WELLBEING;

EID: 84877679896     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.4061/2010/249842     Document Type: Review

References (117)

1. Compston A., Coles A., Multiple sclerosis The Lancet 2008 372 9648 1502 1517
2. Lassmann H., Brck W., Lucchinetti C. F., The immunopathology of multiple sclerosis: an overview Brain Pathology 2007 17 2 210 218 (Pubitemid 46466140)
3. McFarland H. F., Martin R., Multiple sclerosis: a complicated picture of autoimmunity Nature Immunology 2007 8 9 913 919 (Pubitemid 47300005)
4. Lopez-Diego R. S., Weiner H. L., Novel therapeutic strategies for multiple sclerosisa multifaceted adversary Nature Reviews Drug Discovery 2008 7 11 909 925
5. Archelos J. J., Hartung H. P., Pathogenetic role of autoantibodies in neurological diseases Trends in Neurosciences 2000 23 7 317 327 (Pubitemid 30387047)
6. Trapp B. D., Pathogenesis of multiple sclerosis: the eyes only see what the mind is prepared to comprehend Annals of Neurology 2004 55 4 455 457 (Pubitemid 38391961)
7. Oksenberg J. R., Baranzini S. E., Multiple sclerosis genetics-is the glass half full, or half empty? Nature Reviews Neurology 2010 6 8 429 437
8. Lauer K., Environmental risk factors in multiple sclerosis Expert Review of Neurotherapeutics 2010 10 3 421 440
9. Ramagopalan S. V., Dobson R., Meier U. C., Giovannoni G., Multiple sclerosis: risk factors, prodromes, and potential causal pathways The Lancet Neurology 2010 9 7 727 739
10. Serafini B., Rosicarelli B., Franciotta D., Magliozzi R., Reynolds R., Cinque P., Andreoni L., Trivedi P., Salvetti M., Faggioni A., Aloisi F., Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain Journal of Experimental Medicine 2007 204 12 2899 2912 (Pubitemid 350179559)
11. Lnemann J. D., Kamradt T., Martin R., Mnz C., Epstein-Barr virus: environmental trigger of multiple sclerosis? Journal of Virology 2007 81 13 6777 6784 (Pubitemid 46986614)
12. Salvetti M., Giovannoni G., Aloisi F., Epstein-Barr virus and multiple sclerosis Current Opinion in Neurology 2009 22 3 201 206
13. Mameli G., Astone V., Arru G., Marconi S., Lovato L., Serra C., Sotgiu S., Bonetti B., Dolei A., Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not human herpesvirus 6 Journal of General Virology 2007 88 1 264 274 (Pubitemid 46085138)
14. Perron H., Lang A., The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation Clinical Reviews in Allergy and Immunology 2010 39 1 51 61
15. WHO, WHO and Multiple Sclerosis International Federation Atlas: Multiple Sclerosis Resources in the World 2008 Geneva, Switzerland World Health Organisation
16. Thompson A. J., Multiple sclerosisa global disorder and still poorly managed The Lancet Neurology 2008 7 12 1078 1079
17. Payne A., Nutrition and diet in the clinical management of multiple sclerosis Journal of Human Nutrition and Dietetics 2001 14 5 349 357 (Pubitemid 33014888)
18. Coo H., Aronson K. J., A systematic review of several potential non-genetic risk factors for multiple sclerosis Neuroepidemiology 2004 23 1-2 1 12 (Pubitemid 38142267)
19. Schwarz S., Leweling H., Multiple sclerosis and nutrition Multiple Sclerosis 2005 11 1 24 32 (Pubitemid 40259971)
20. Farinotti M., Simi S., Di Pietrantonj C., McDowell N., Brait L., Lupo D., Filippini G., Dietary interventions for multiple sclerosis Cochrane Database of Systematic Reviews 2007 1
21. Riccio P., Haas H., Liuzzi G. M., Rossano R., Falus A., New diagnostic and therapeutic options for the treatment of multiple sclerosis Clinical Applications for Immunomics 2008 New York, NY, USA Springer Science + Business Media LLC 205 226
22. Schwarz S., Knorr C., Geiger H., Flachenecker P., Complementary and alternative medicine for multiple sclerosis Multiple Sclerosis 2008 14 8 1113 1119
23. Leong E. M., Semple S. J., Angley M., Siebert W., Petkov J., McKinnon R. A., Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why? Complementary Therapies in Medicine 2009 17 4 216 223
24. Yadav V., Shinto L., Bourdette D., Complementary and alternative medicine for the treatment of multiple sclerosis Expert Review of Clinical Immunology 2010 6 3 381 395
25. Desvergne B., Michalik L., Wahli W., Transcriptional regulation of metabolism Physiological Reviews 2006 86 2 465 514
26. Schrader M., Fahimi H. D., The peroxisome: still a mysterious organelle Histochemistry and Cell Biology 2008 129 4 421 440
27. Heneka M. T., Landreth G. E., PPARs in the brain Biochimica et Biophysica Acta 2007 1771 8 1031 1045 (Pubitemid 47208548)
28. Haigis M. C., Sinclair D. A., Mammalian sirtuins: biological insights and disease relevance Annual Review of Pathology 2010 5 253 295
29. Steinberg G. R., Kemp B. E., AMPK in health and disease Physiological Reviews 2009 89 3 1025 1078
30. Ronnett G. V., Ramamurthy S., Kleman A. M., Landree L. E., Aja S., AMPK in the brain: its roles in energy balance and neuroprotection Journal of Neurochemistry 2009 109 1 17 23
31. Cant C., Gerhart-Hines Z., Feige J. N., Lagouge M., Noriega L., Milne J. C., Elliott P. J., Puigserver P., Auwerx J., AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity Nature 2009 458 7241 1056 1060
32. Mitro N., Mak P. A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., Saez E., The nuclear receptor LXR is a glucose sensor Nature 2007 445 7124 219 223 (Pubitemid 46095727)
33. Flores N., Durn C., Blasco M. R., Puerta C., Dorado B., Garca-Merino A., Ballester S., NF B and AP-1 DNA binding activity in patients with multiple sclerosis Journal of Neuroimmunology 2003 135 1-2 141 147 (Pubitemid 36170161)
34. Wang K., Wan Y. J. Y., Nuclear receptors and inflammatory diseases Experimental Biology and Medicine 2008 233 5 496 506 (Pubitemid 351657351)
35. Bensinger S. J., Tontonoz P., Integration of metabolism and inflammation by lipid-activated nuclear receptors Nature 2008 454 7203 470 477
36. Swank R. L., Multiple sclerosis: a correlation of its incidence with dietary fat The American Journal of the Medical Sciences 1950 220 4 421 430
37. Swank R. L., Goodwin J., Review of MS patient survival on a Swank low saturated fat diet Nutrition 2003 19 2 161 162 (Pubitemid 36194478)
38. Swank R. L., Goodwin J. W., How saturated fats may be a causative factor in multiple sclerosis and other diseases Nutrition 2003 19 5 478 (Pubitemid 36444701)
39. Jump D. B., Clarke S. D., Regulation of gene expression by dietary fat Annual Review of Nutrition 1999 19 63 90 (Pubitemid 29380597)
40. Wekerle H., Hohlfeld R., Molecular mimicry in multiple sclerosis The New England Journal of Medicine 2003 349 2 185 186 (Pubitemid 36818790)
41. Butcher J., The distribution of multiple sclerosis in relation to the dairy industry and milk consumption New Zealand Medical Journal 1976 83 566 427 430
42. Butcher P. J., Milk consumption and multiple sclerosis: an etiological hypothesis Medical Hypotheses 1986 19 2 169 178 (Pubitemid 16130771)
43. Malosse D., Perron H., Sasco A., Seigneurin J. M., Correlation between milk and dairy product consumption and multiple sclerosis prevalence: a worldwide study Neuroepidemiology 1992 11 4-6 304 312 (Pubitemid 23044221)
44. Riccio P., The proteins of the milk fat globule membrane in the balance Trends in Food Science and Technology 2004 15 9 458 461 (Pubitemid 39040022)
45. Mather I. H., A review and proposed nomenclature for major proteins of the milk-fat globule membrane Journal of Dairy Science 2000 83 2 203 247
46. Stefferl A., Schubart A., Storch M., Amini A., Mather I., Lassmann H., Linington C., Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune Encephalomyelitis Journal of Immunology 2000 165 5 2859 2865 (Pubitemid 30660738)
47. Kennel de March A., de Bouwerie M., Kolopp-Sarda M. N., Faure G. C., Béné M. C., Bernard C. C. A., Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis Journal of Neuroimmunology 2003 135 1-2 117 125 (Pubitemid 36170158)
48. Guggenmos J., Schubart A. S., Ogg S., Andersson M., Olsson T., Mather I. H., Linington C., Antibody cross-reactivity between myelin oligodendrocyte glycoprotein and the milk protein butyrophilin in multiple sclerosis Journal of Immunology 2004 172 1 661 668 (Pubitemid 38020525)
49. Vojdani A., Campbell A. W., Anyanwu E., Kashanian A., Bock K., Vojdani E., Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A Journal of Neuroimmunology 2002 129 1-2 168 177 (Pubitemid 34874922)
50. Moss M., Freed D., The cow and the coronary: epidemiology, biochemistry and immunology International Journal of Cardiology 2003 87 2-3 203 216 (Pubitemid 36135977)
51. Spitsberg V. L., Invited review: bovine milk fat globule membrane as a potential nutraceutical Journal of Dairy Science 2005 88 7 2289 2294 (Pubitemid 41044832)
52. Gilgun-Sherki Y., Melamed E., Offen D., The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy Journal of Neurology 2004 251 3 261 268 (Pubitemid 38387142)
53. Steiner J., Haughey N., Li W., Venkatesan A., Anderson C., Reid R., Malpica T., Pocernich C., Butterfield D. A., Nath A., Oxidative stress and therapeutic approaches in HIV dementia Antioxidants Redox Signaling 2006 8 11-12 2089 2100 (Pubitemid 46489633)
54. Bravo L., Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance Nutrition Reviews 1998 56 11 317 333 (Pubitemid 28532456)
55. Manach C., Williamson G., Morand C., Scalbert A., Rémésy C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies The American Journal of Clinical Nutrition 2005 81 supplement 1 230S 242S
56. Zheng L. T., Ryu G. M., Kwon B. M., Lee W. H., Suk K., Anti-inflammatory effects of catechols in lipopolysaccharide-stimulated microglia cells: inhibition of microglial neurotoxicity European Journal of Pharmacology 2008 588 1 106 113
57. Kanashiro A., Souza J. G., Kabeya L. M., Azzolini A. E. C. S., Lucisano-Valim Y. M., Elastase release by stimulated neutrophils inhibited by flavonoids: importance of the catechol group Zeitschrift fr Naturforschung Section C 2007 62 5-6 357 361 (Pubitemid 47605218)
58. Boots A. W., Haenen G. R. M. M., Bast A., Health effects of quercetin: from antioxidant to nutraceutical European Journal of Pharmacology 2008 585 2-3 325 337
59. Sternberg Z., Chadha K., Lieberman A., Hojnacki D., Drake A., Zamboni P., Rocco P., Grazioli E., Weinstock-Guttman B., Munschauer F., Quercetin and interferon- modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients Journal of Neuroimmunology 2008 205 1-2 142 147
60. Youdim K. A., Qaiser M. Z., Begley D. J., Rice-Evans C. A., Abbott N. J., Flavonoid permeability across an in situ model of the blood-brain barrier Free Radical Biology Medicine 2004 36 5 592 604 (Pubitemid 38230176)
61. Hendriks J. J. A., de Vries H. E., van der Pol S. M. A., van den Berg T. K., van Tol E. A. F., Dijkstra C. D., Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study Biochemical Pharmacology 2003 65 5 877 885 (Pubitemid 36293703)
62. Min Y. D., Choi C. H., Bark H., Son H. Y., Park H. H., Lee S., Park J. W., Park E. K., Shin H. I., Kim S. H., Quercetin inhibits expression of inflammatory cytokines through attenuation of NF- B and p38 MAPK in HMC-1 human mast cell line Inflammation Research 2007 56 5 210 215 (Pubitemid 46985839)
63. Sagar S. M., Yance D., Wong R. K., Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancerpart 1 Current Oncology 2006 13 1 14 26
64. Sharma V., Mishra M., Ghosh S., Tewari R., Basu A., Seth P., Sen E., Modulation of interleukin-1 mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection Brain Research Bulletin 2007 73 13 55 63 (Pubitemid 46710246)
65. Muthian G., Bright J. J., Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte Journal of Clinical Immunology 2004 24 5 542 552 (Pubitemid 39221672)
66. Harwood M., Danielewska-Nikiel B., Borzelleca J. F., Flamm G. W., Williams G. M., Lines T. C., A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties Food and Chemical Toxicology 2007 45 11 2179 2205 (Pubitemid 47451573)
67. Boots A. W., Haenen G. R. M. M., Bast A., Health effects of quercetin: from antioxidant to nutraceutical European Journal of Pharmacology 2008 585 2-3 325 337
68. Singh N. P., Hegde V. L., Hofseth L. J., Nagarkatti M., Nagarkatti P. S., Resveratrol (trans-3,5, 4′ -trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor Molecular Pharmacology 2007 72 6 1508 1521 (Pubitemid 350146088)
69. Shakibaei M., Harikumar K. B., Aggarwal B. B., Review: resveratrol addiction: to die or not to die Molecular Nutrition and Research 2009 53 1 115 128
70. Das S., Das D. K., Anti-inflammatory responses of resveratrol Inflammation Allergy-Drug Targets 2007 6 3 168 173 (Pubitemid 47455785)
71. Cheng G., Zhang X., Gao D., Jiang X., Dong W., Resveratrol inhibits MMP-9 expression by up-regulating PPAR expression in an oxygen glucose deprivation-exposed neuron model Neuroscience Letters 2009 451 2 105 108
72. Goel A., Kunnumakkara A. B., Aggarwal B. B., Curcumin as "Curecumin": from kitchen to clinic Biochemical Pharmacology 2008 75 4 787 809
73. Friedman M., Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas Molecular Nutrition and Research 2007 51 1 116 134 (Pubitemid 46144767)
74. Demeule M., Brossard M., Pagé M., Gingras D., Béliveau R., Matrix metalloproteinase inhibition by green tea catechins Biochimica et Biophysica Acta 2000 1478 1 51 60 (Pubitemid 30136138)
75. Koo S. I., Noh S. K., Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect The Journal of Nutritional Biochemistry 2007 18 3 179 183 (Pubitemid 46216812)
76. Bhuvaneswari V., Nagini S., Lycopene: a review of its potential as an anticancer agent Current Medicinal Chemistry-Anti-Cancer Agents 2005 5 6 627 635 (Pubitemid 41601060)
77. Rao A. V., Rao L. G., Carotenoids and human health Pharmacological Research 2007 55 3 207 216 (Pubitemid 46518154)
78. Rietjens S. J., Bast A., Haenen G. R. M. M., New insights into controversies on the antioxidant potential of the olive oil antioxidant hydroxytyrosol Journal of Agricultural and Food Chemistry 2007 55 18 7609 7614 (Pubitemid 47492322)
79. de Paula M. L., Rodrigues D. H., Teixeira H. C., Barsante M. M., Souza M. A., Ferreira A. P., Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis International Immunopharmacology 2008 8 9 1291 1297
80. Salinthone S., Schillace R. V., Marracci G. H., Bourdette D. N., Carr D. W., Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells Journal of Neuroimmunology 2008 199 1-2 46 55
81. Morini M., Roccatagliata L., Dell'Eva R., Pedemonte E., Furlan R., Minghelli S., Giunti D., Pfeffer U., Marchese M., Noonan D., Mancardi G., Albini A., Uccelli A., -lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis Journal of Neuroimmunology 2004 148 1-2 146 153 (Pubitemid 38229567)
82. Schreibelt G., Musters R. J. P., Reijerkerk A., de Groot L. R., van der Pol S. M. A., Hendrikx E. M. L., Dpp ED. D., Dijkstra C. D., Drukarch B., de Vries H. E., Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity Journal of Immunology 2006 177 4 2630 2637 (Pubitemid 44201022)
83. Yadav V., Marracci G. H., Munar M. Y., Cherala G., Stuber L. E., Alvarez L., Shinto L., Koop D. R., Bourdette D. N., Pharmacokinetic study of acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters Multiple Sclerosis 2010 16 4 387 397
84. de Boer A. G., Gaillard P. J., Blood-brain barrier dysfunction and recovery Journal of Neural Transmission 2006 113 4 455 462
85. Smolders J., Damoiseaux J., Menheere P., Hupperts R., Vitamin D as an immune modulator in multiple sclerosis, a review Journal of Neuroimmunology 2008 194 1-2 7 17
86. Pierrot-Deseilligny C., Souberbielle J. C., Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 2010 133 7 1869 1888
87. Ascherio A., Munger K. L., Simon K. C., Vitamin D and multiple sclerosis The Lancet Neurology 2010 9 6 599 612
88. Mastronardi F. G., Min W., Wang H., Winer S., Dosch M., Boggs J. M., Moscarello M. A., Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN- plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance Journal of Immunology 2004 172 10 6418 6426 (Pubitemid 38621251)
89. Boosalis M. G., The role of selenium in chronic disease Nutrition in Clinical Practice 2008 23 2 152 160 (Pubitemid 351508220)
90. Schmitz G., Ecker J., The opposing effects of n-3 and n-6 fatty acids Progress in Lipid Research 2008 47 2 147 155
91. Farooqui A. A., Horrocks L. A., Farooqui T., Modulation of inflammation in brain: a matter of fat Journal of Neurochemistry 2007 101 3 577 599 (Pubitemid 46633316)
92. Calder P. C., n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases The American Journal of Clinical Nutrition 2006 83 supplement 6 1505S 1519S (Pubitemid 44713092)
93. Zamaria N., Alteration of polyunsaturated fatty acids status and metabolism in health and disease Reproduction Nutrition Development 2004 44 3 273 282 (Pubitemid 39198969)
94. Liuzzi G. M., Latronico T., Rossano R., Viggiani S., Fasano A., Riccio P., Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cellsimplications for complementary multiple sclerosis treatment Neurochemical Research 2007 32 12 2184 2193 (Pubitemid 350059862)
95. Liuzzi G. M., Latronico T., Fasano A., Carlone G., Riccio P., Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment Multiple Sclerosis 2004 10 3 290 297 (Pubitemid 38807457)
96. McCabe A. J., Wallace J. M. W., Gilmore W. S., McGlynn H., Strain S. J., Docosahexaenoic acid reduces in vitro invasion of renal cell carcinoma by elevated levels of tissue inhibitor of metalloproteinase-1 The Journal of Nutritional Biochemistry 2005 16 1 17 22 (Pubitemid 40052712)
97. Shinto L., Marracci G., Baldauf-Wagner S., Strehlow A., Yadav V., Stuber L., Bourdette D., Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis Prostaglandins Leukotrienes and Essential Fatty Acids 2009 80 2-3 131 136
98. Mehta L. R., Dworkin R. H., Schwid S. R., Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis Nature Clinical Practice Neurology 2009 5 2 82 92
99. Weinstock-Guttman B., Baier M., Park Y., Feichter J., Lee-Kwen P., Gallagher E., Venkatraman J., Meksawan K., Deinehert S., Pendergast D., Awad A. B., Ramanathan M., Munschauer F., Rudick R., Low fat dietary intervention with -3 fatty acid supplementation in multiple sclerosis patients Prostaglandins Leukotrienes and Essential Fatty Acids 2005 73 5 397 404 (Pubitemid 41375637)
100. Coluccia A., Borracci P., Renna G., Giustino A., Latronico T., Riccio P., Carrat M. R., Developmental omega-3 supplementation improves motor skills in juvenile-adult rats International Journal of Developmental Neuroscience 2009 27 6 599 605
101. Russo G. L., Ins and outs of dietary phytochemicals in cancer chemoprevention Biochemical Pharmacology 2007 74 4 533 544 (Pubitemid 47042006)
102. Halliwell B., Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Archives of Biochemistry and Biophysics 2008 476 2 107 112
103. Briet F., Keith M., Leong-Poi H., Kadakia A., Aba-Alkhail K., Giliberto J. P., Stewart D., Errett L., David Mazer C., Triple nutrient supplementation improves survival, infarct size and cardiac function following myocardial infarction in rats Nutrition, Metabolism and Cardiovascular Diseases 2008 18 10 691 699
104. Suchy J., Chan A., Shea T. B., Dietary supplementation with a combination of -lipoic acid, acetyl-l-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance Nutrition Research 2009 29 1 70 74
105. Candelario-Jalil E., de Oliveira A. C. P., Grf S., Bhatia H. S., Hll M., Muoz E., Fiebich B. L., Resveratrol potently reduces prostaglandin E 2 production and free radical formation in lipopolysaccharide-activated primary rat microglia Journal of Neuroinflammation 2007 4, article 25
106. Piccio L., Stark J. L., Cross A. H., Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis Journal of Leukocyte Biology 2008 84 4 940 948
107. Fontn-Lozano A., Lpez-Lluch G., Delgado-Garca J. M., Navas P., Carrin A. M., Molecular bases of caloric restriction regulation of neuronal synaptic plasticity Molecular Neurobiology 2008 38 2 167 177
108. Sprecher D. L., Lipids, lipoproteins, and peroxisome proliferator activated receptor- American Journal of Cardiology 2007 100 11 S20 S24
109. Yasari S., Wang D., Prud'homme D., Jankowski M., Gutkowska J., Lavoie J.-M., Exercise training decreases plasma leptin levels and the expression of hepatic leptin receptor-a, -b, and, -e in rats Molecular and Cellular Biochemistry 2009 324 1-2 13 20
110. Nath N., Khan M., Rattan R., Mangalam A., Makkar R. S., Meester C. D., Bertrand L., Singh I., Chen Y., Viollet B., Giri S., Loss of AMPK exacerbates experimental autoimmune encephalomyelitis disease severity Biochemical and Biophysical Research Communications 2009 386 1 16 20
111. Nath N., Khan M., Paintlia M. K., Hoda M. N., Giri S., Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis Journal of Immunology 2009 182 12 8005 8014
112. Marrie R. A., Horwitz R., Cutter G., Tyry T., Campagnolo D., Vollmer T., High frequency of adverse health behaviors in multiple sclerosis Multiple Sclerosis 2009 15 1 105 113
113. Liuzzi G. M., Latronico T., Bran M. T., Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients Neurochemical Research 2011 36 3 518 527
114. Verbeek R., van Tol E. A. F., van Noort J. M., Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice Biochemical Pharmacology 2005 70 2 220 228 (Pubitemid 40814404)
115. Silberberg M., Morand C., Mathevon T., Besson C., Manach C., Scalbert A., Remesy C., The bioavailability of polyphenols is highly governed by the capacity of the intestine and of the liver to secrete conjugated metabolites European Journal of Nutrition 2006 45 2 88 96 (Pubitemid 43345201)
116. D'Archivio M., Filesi C., Di Benedetto R., Gargiulo R., Giovannini C., Masella R., Polyphenols, dietary sources and bioavailability Annali dell'Istituto Superiore di Sanit 2007 43 4 348 361
117. Martin H., Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components Mutation Research 2009 669 1-2 1 7